20/20 GeneSystems, Inc. Ranks No. 770 on the 2021 Inc. 5000, With Three-Year Revenue Growth of 640 Percent
Inc. magazine today revealed that 20/20 GeneSystems, Inc. is No. 770 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies
Only on 7: Can antibody blood tests confirm you’re immune, get you out of quarantine?
Dr. Michael Ross is on the company’s board. He says, “the beauty of it is if you have IgG, the assumption is at that point that you are protected, you’ve been exposed, i.e., you can go back to work; i.e. you can visit your grandmother.”
These 17 Maryland biotech companies are collaborating in the fight against COVID-19
As more cases of COVID-19 are being reported and leaders seek tests and treatments, biotech companies are stepping up efforts to develop new tests and treatments.
20/20 Launching First COVID-19 Rapid Antibody Test Authorized by FDA for Point-of-Care Use
20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc., announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits.
20/20 launching first COVID-19 rapid antibody test authorized by FDA
20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc., announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits. These kits were the first to receive an emergency use authorization (EUA) from the FDA for point-of-care (POC) use with fingerstick blood samples on September 23. According to the FDA